DBCO-PEG8-VKG-CPT2 is a drug-linker conjugate for ADCs, consisting of a topoisomerase 1 inhibitor (7-MAD-MDCPT) and a stable cleavable linker (DBCO-PEG8-VKG). This compound is applicable for the synthesis of ADCs.
Target:
Drug-Linker Conjugates for ADC|||Topoisomerase
* VAT and and shipping costs not included. Errors and price changes excepted